LYTIR

Company · LGND

Ligand Pharmaceuticals Incorporated

Name as listed on its exchange; filed with the SEC as LIGAND PHARMACEUTICALS INC.

Nasdaq's symbol directory lists LGND on Nasdaq as “Ligand Pharmaceuticals Incorporated - Common Stock”.

In the 12 months to Nov 8, 2026: insiders sold on 12 occasions ($20.7M); 5 planned-sale notices; 1 filing by holders of 5% or more; 4 congressional trade disclosures; 3 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $20.7M in total.Jun: Insider sales $2.2MJul: Insider sales $1.6MAug: Insider sales $12.8MSep: Insider sales $342KOct: Insider sales $2.0MNov: Insider sales $1.9MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $20.7M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Octavio Espinoza, Chief Financial Officer sold on 1 day all under a 10b5-1 plan latest Aug 12, 2026 sold $9.2M
  2. Andrew Reardon, CLO & Secretary sold on 4 days all under a 10b5-1 plan latest Nov 2, 2026 sold $6.1M
  3. Jason Haas sold on 2 days latest Aug 12, 2026 sold $3.7M
  4. Aryeh Jason sold on 3 days latest Nov 4, 2026 sold $766K
  5. Sabba Stephen L sold on 1 day latest Jun 16, 2026 sold $545K
  6. Zimmermann Martine sold on 1 day latest Sep 10, 2026 sold $342K
Every trade (12)
  1. SELLAryeh Jason sold Nov 4, 2026 282 shares filing $90K
  2. SELLAndrew Reardon, CLO & Secretary sold Nov 2, 2026 5,000 shares 13 legs combined 10b5-1 plan (scheduled) filing $1.6M
  3. SELLAryeh Jason sold Nov 2, 2026 700 shares filing $224K
  4. SELLAryeh Jason sold Oct 30, 2026 1,411 shares 5 legs combined filing $452K
  5. SELLAndrew Reardon, CLO & Secretary sold Oct 2, 2026 5,000 shares 6 legs combined 10b5-1 plan (scheduled) filing $1.5M
  6. SELLZimmermann Martine sold Sep 10, 2026 1,200 shares filing $342K
  7. SELLOctavio Espinoza, Chief Financial Officer sold Aug 12, 2026 31,641 shares 10b5-1 plan (scheduled) filing $9.2M
  8. SELLJason Haas sold Aug 12, 2026 7,138 shares filing $2.1M
  9. SELLAndrew Reardon, CLO & Secretary sold Aug 3, 2026 5,000 shares 10 legs combined 10b5-1 plan (scheduled) filing $1.4M
  10. SELLAndrew Reardon, CLO & Secretary sold Jul 1, 2026 5,000 shares 8 legs combined 10b5-1 plan (scheduled) filing $1.6M
  11. SELLSabba Stephen L sold Jun 16, 2026 2,145 shares filing $545K
  12. SELLJason Haas sold Jun 12, 2026 6,461 shares 2 legs combined filing $1.7M

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. Aryeh Jason filed Nov 4, 2026 Director 282 shares planned sale date 11/04/2026 filing $90K
  2. Aryeh Jason filed Nov 2, 2026 Director 700 shares planned sale date 11/02/2026 filing $222K
  3. JASON M ARYEH filed Oct 30, 2026 Director 1,209 shares planned sale date 10/30/2026 filing $385K
  4. Aryeh Jason filed Oct 30, 2026 Director 202 shares planned sale date 10/30/2026 filing $65K
  5. MARTINE ZIMMERMANN filed Sep 10, 2026 Director 1,200 shares planned sale date 09/10/2026 filing $342K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Invesco Ltd. filed Aug 13, 2026 Schedule 13G passive filing 6.1%

Congress · STOCK Act

The Althing

Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.

  1. Gilbert Cisneros (D-CA31): Purchase May 29, 2026 reported Jun 8, 2026 one of 103 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  2. Gilbert Cisneros (D-CA31): Purchase Mar 3, 2026 reported Apr 7, 2026 one of 141 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  3. Gilbert Cisneros (D-CA31): Purchase Jan 15, 2026 reported Feb 13, 2026 one of 151 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  4. Gilbert Cisneros (D-CA31): Purchase Jan 5, 2026 reported Feb 13, 2026 one of 151 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Oct 29, 2026
  2. Regulation FD disclosure; Other events filing Sep 24, 2026
  3. Regulation FD disclosure filing Sep 22, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.